The Sterile Injectable Contract Manufacturing Market was valued at US$ 18,395.07 Million in 2025 and is projected to reach US$ 49,738.76 Million by 2034, registering a CAGR of 11.69% during 2026–2034. The market is expanding as pharmaceutical and biotechnology companies increasingly outsource the development, manufacturing, filling, and packaging of...

Market Overview The sterile injectable contract manufacturing market was valued at USD 24.15 billion in 2025 and is projected to reach USD 68.05 billion by 2034, growing at a CAGR of 12.2% from 2026 to 2034, according to Polaris Market Research. The report finds that sponsors are looking to external partners for specialized sterile capabilities as drug pipelines become more complex, and it...